Metabolites with SARS-CoV-2 Inhibitory Activity Identified from Human Microbiome Commensals

The COVID-19 pandemic has highlighted the need to identify additional antiviral small molecules to complement existing therapies. Although increasing evidence suggests that metabolites produced by the human microbiome have diverse biological activities, their antiviral properties remain poorly explo...

Descripción completa

Detalles Bibliográficos
Autores principales: Piscotta, Frank J., Hoffmann, Hans-Heinrich, Choi, Young Joo, Small, Gabriel I., Ashbrook, Alison W., Koirala, Bimal, Campbell, Elizabeth A., Darst, Seth A., Rice, Charles M., Brady, Sean F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636105/
https://www.ncbi.nlm.nih.gov/pubmed/34851166
http://dx.doi.org/10.1128/mSphere.00711-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636105/
https://www.ncbi.nlm.nih.gov/pubmed/34851166
http://dx.doi.org/10.1128/mSphere.00711-21

Ejemplares similares